Indeed, we have identified a chimeric FGF19v protein that fits these criteria; it ameliorates hyperglycemia and hyperinsulinemia without a detectable increase in hepatic AFP expression in ob/ob mice. This evidence concerns the gene AFP and Hyperinsulinemia.